ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug GEN1057 tested in early trial – but study stopped early
Disease control TerminatedThis early-stage trial tested a new antibody drug called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and see how the drug behaves in the body. The study was terminated early, so results ar…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Liver impairment study for cancer drug tazemetostat halted early
Knowledge-focused TerminatedThis study looked at how the cancer drug tazemetostat is processed in the body of people with advanced solid tumors who also have moderate or severe liver impairment. Researchers compared drug levels in these patients to those with normal liver function. The trial was terminated …
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC